Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial

Autor: Mahon, François-Xavier, Réa, Delphine, Guilhot, Joëlle, Guilhot, François, Huguet, Françoise, Nicolini, Franck, Legros, Laurence, Charbonnier, Aude, Guerci, Agnès, Varet, Bruno, Etienne, Gabriel, Reiffers, Josy, Rousselot, Philippe
Zdroj: In Lancet Oncology 2010 11(11):1029-1035
Databáze: ScienceDirect